Back to Scanner
DYN
NASDAQRS 23Score 33Dyne Therapeutics, Inc.
HealthcareBiotechnology$3.11B1 setup passing
$18.73
-0.5% ($0.09)
-25.1% from 52W High
P/E (TTM)
-5.40
Fwd P/E
—
PEG
—
Analyst Upside
+126.9%
EPS Growth
—
Gross Margin
0.0%
ROE
-61.5%
D/E
0.02
Div Yield
0.0%
Avg Volume
1.9M
Price Chart
Key Levels
SMA 200
$15.62
SMA 50
$17.19
Price
$18.73
52W High
$25.01
Target
$42.50
Setup Radar
1/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst